Package 0178-0500-01

Brand: lithostat

Generic: acetohydroxamic acid
NDC Package

Package Facts

Identity

Package NDC 0178-0500-01
Digits Only 0178050001
Product NDC 0178-0500
Description

100 TABLET in 1 BOTTLE (0178-0500-01)

Marketing

Marketing Status
Marketed Since 1983-05-31
Brand lithostat
Generic acetohydroxamic acid
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "47e7b4dd-b3b1-f6a0-e063-6294a90a1bca", "openfda": {"nui": ["N0000175611", "N0000175087"], "upc": ["0301780500019"], "unii": ["4RZ82L2GY5"], "rxcui": ["197308", "213557"], "spl_set_id": ["6660b616-a82d-9109-19ce-2bdf9747acea"], "pharm_class_epc": ["Urease Inhibitor [EPC]"], "pharm_class_moa": ["Urease Inhibitors [MoA]"], "manufacturer_name": ["Mission Pharmacal Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (0178-0500-01)", "package_ndc": "0178-0500-01", "marketing_start_date": "19830531"}], "brand_name": "Lithostat", "product_id": "0178-0500_47e7b4dd-b3b1-f6a0-e063-6294a90a1bca", "dosage_form": "TABLET", "pharm_class": ["Urease Inhibitor [EPC]", "Urease Inhibitors [MoA]"], "product_ndc": "0178-0500", "generic_name": "acetohydroxamic acid", "labeler_name": "Mission Pharmacal Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lithostat", "active_ingredients": [{"name": "ACETOHYDROXAMIC ACID", "strength": "250 mg/1"}], "application_number": "NDA018749", "marketing_category": "NDA", "marketing_start_date": "19830531", "listing_expiration_date": "20271231"}